Imaging biomarker data interrogated by the IXI™ Platform, together with IXICO’s expert scientists and world-renowned neuroradiologists, translates complex data into clinically meaningful information.
The Platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data that may be generated in the course of a clinical study.
Image analysis algorithms are disease contextualised and data-driven to analyse data from people with specific neurological diseases. Algorithms are also robust to inherent variability between patients, disease stages, scanners and image quality to provide accurate analysis results.
Highly differentiated algorithms measuring existing and previously inaccessible biomarkers at scale, with high precision
Performing brain region analysis on individual scans to measure brain volume both at a single time point and across multiple time points.
Delivering advanced clinical endpoints while reducing variability by automating traceability and consistent reproducibility into every dataset, all underpinned by a highly granular audit trail.
Reduces data upload, management and analysis burden for sites, sponsors and readers through seamless integration with existing workflows without the need for additional software or tools.
Capabilities in all clinical trial phases, including patient stratification and exploratory endpoints, as well as use for post-market assessment and clinical diagnostics.
Distinct technologies and scientific expertise to meet specific neurological disease needs with the required specialism and complex understanding of each different indication.